Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M31.6Revenue (TTM) $M13.8Net Margin (%)-65.1Altman Z-Score-4.5
Enterprise Value $M33.9EPS (TTM) $-0.8Operating Margin %-69.7Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.2Pre-tax Margin (%)-71.7Higher ROA y-yY
Price/Book1.010-y EBITDA Growth Rate %-11.7Quick Ratio1.2Cash flow > EarningsY
Price/Sales2.35-y EBITDA Growth Rate %-8.3Current Ratio2.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-18.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-27.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M10.0ROIC % (ttm)-31.8Gross Margin Increase y-yY

Gurus Latest Trades with KOOL

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

KOOL is held by these investors:

KOOL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Boyalife (Hong Kong) Ltd10% Owner 2016-12-26Buy6,102,942$2.5236.11view
Harris KennethFormer Director/Officer 2015-11-10Sell4,043$12-71.42view
Harris KennethFormer Director/Officer 2015-11-03Sell526$12-71.42view
Harris KennethFormer Director/Officer 2015-10-29Sell432$12-71.42view
Plavan Matthew TFormer CEO 2015-09-02Sell864$13.6-74.78view
Rhein Denis MichaelDirector 2014-12-01Sell0$0-74.78view
ENGLE J MELVILLEChairman & CEO 2011-03-10Buy1,125$46-92.54view
ARTILES JORGEVP, Quality/Regulatory Affairs 2010-01-13Buy5$48.8-92.97view
ENGLE J MELVILLECEO 2009-09-25Buy1,250$45.6-92.48view
MCENANY PATRICK JDirector 2009-05-19Buy313$46.4-92.61view

Press Releases about KOOL :

Quarterly/Annual Reports about KOOL:

News about KOOL:

Articles On GuruFocus.com
Cesca Therapeutics to Present at the Advanced Cell Therapy Shanghai Summit 2017 Nov 14 2017 
Cesca Therapeutics to Announce Financial Results for the Three Months Ended September 30, 2017 and H Nov 07 2017 
Cesca Receives Notice of Allowance for U.S. Patent Application Covering a Novel Method of Cell Separ Oct 03 2017 
Cesca Therapeutics to Present at the 2017 Cell & Gene Meeting on the Mesa Sep 27 2017 
Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017 Sep 25 2017 
Cesca Therapeutics to Announce Fiscal Fourth Quarter and Full Year 2017 Financial Results and Host C Sep 12 2017 
CESCA Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference Sep 05 2017 
Cesca Therapeutics to Participate in the CAR-TCR Summit 2017 Aug 31 2017 
Cesca Therapeutics Announces International Distribution Agreement With Boyalife WSN Ltd. Aug 24 2017 
Cesca Therapeutics Announces Issuance of New Cellular Processing Patent Poised to Revolutionize CAR- Jul 28 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat